The use of prostate-specific antigen as a surrogate end point in the treatment of patients with hormone refractory prostate cancer

D. C. Smith, K. J. Pienta

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The use of prostate-specific antigen as a surrogate end point in the treatment of patients with hormone refractory prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences